UTHR files patent suit against Liquidia seeking to block YUTREPIA commercialization

Liquidia Corp

UTHR sued Liquidia on May 9, 2025 alleging infringement of the '782 patent and seeking an injunction against YUTREPIA launch if FDA-approved.
UTHR is not seeking an injunction against the FDA; PDUFA goal date for YUTREPIA remains May 24, 2025.
The '782 patent is from the same family as the '793 patent, which was invalidated by the PTAB and upheld through appeals.
Liquidia CEO states they expect to invalidate these claims as done previously with the '793 patent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.